Overall Count and Share for 'Biocon Bristol-Myers Squibb Research and Development Center (BBRC)' based on the 12-month time frame mentioned above. Note: Articles may be assigned to more than one ...

MUMBAI, Sept 27 (Reuters) - Biocon Ltd said on Monday it had strengthened its existing research partnership with Cuba-based Center of Molecular Immunology (CMI) to create a product pipeline focused on ...

He will also participate in a fireside chat at the ENDPOINTS at JPM26 conference on Tuesday, January 13 titled, "Achieving ...

Q3 Healthcare Results Preview: Motilal Oswal sees strong Q3 for Laurus Labs, Biocon; hospitals to drive sector momentum ...

Biocon Limited unveils three new oncology biosimilars at a US conference, expanding its global portfolio and advancing ...

Viatris is leaving the biosimilar field just months after winning the landmark FDA approval for the first interchangeable biosimilar product. Biocon Biologics, a subsidiary of Biocon, will buy Viatris ...

These products are among the largest oncology biologics expected to lose exclusivity over the next five years.

BANGALORE, April 19 (Reuters) - India's largest biotechnology firm, Biocon Ltd. , sees strong growth in the current fiscal year on new drug discovery and large research outsourcing services contracts, ...

Biocon Biologics, a subsidiary of Biocon, received a European Union GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug ...

MUMBAI (MarketWatch) -- Biocon Ltd. (532523.BY), an Indian biotechnology company, Wednesday said that its unit, Syngene International Pvt. Ltd., has entered into a research tie-up with U.S.-based ...

Article ‘Count’ and ‘Share’ for Biocon Bristol-Myers Squibb Research and Development Center (BBRC) based on listed parameters only. The articles listed below published by authors from Biocon ...